跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,654 条关于
“VEGFR-TKI”
全部
5,654
临床试验
4,140
药物
777
机构
26
资讯
711
5个月前
HiberCell's HC-7366 Shows Promise in Late-Line Renal Cell Carcinoma with 37% Response Rate in Phase 1b Trial
去年
SUO 2024: Update on Neoadjuvant Therapy Trials in RCC
2个月前
EGFR-TKIs Pose Highest Cardiovascular Risk Among Tyrosine Kinase Inhibitors, Meta-Analysis Finds
9个月前
Belzutifan Shows Sustained Efficacy in Heavily Pretreated Clear Cell Renal Cell Carcinoma Patients
5个月前
Kura Oncology to Present Updated Darlifarnib Combination Data for Renal Cell Carcinoma at IKCS Europe 2026
2年前
Fecal Microbiota Transplant Enhances Immunotherapy Response in Metastatic Renal Cell Carcinoma
去年
GNTbm Presents Promising Preclinical Data for Novel Epigenetic Immune Activator at ASCO 2025
3个月前
China Approves Sintilimab-Fruquintinib Combination for Advanced Renal Cell Carcinoma
去年
ESMO Endorses HLB's CAM-RIVO for First-Line Liver Cancer Treatment Ahead of FDA Decision
去年
FDA-Approved Fotivda Dose Shows Superior Efficacy in Renal Cell Carcinoma Treatment
第 1 页,共 72 页
上一页
下一页